51 evolution-"https:"-"https:"-"https:"-"https:"-"https:"-"https:"-"BioData" positions at Nature Careers in United Kingdom
Sort by
Refine Your Search
-
development of novel technologies to study this problem. We are especially interested in growing our expertise in epitranscriptomics, RNA biology, single-cell/spatial approaches, microenvironment, and
-
while driving strategic development and scientific progress across its remit. Why AFBI? This is an extraordinary opportunity to lead a world-class Institute that delivers meaningful scientific impact
-
aims to deliver world class regulation and improved outcomes for UK patients. We are currently looking for an experienced Principal Scientist (NMR) – Molecular Analysis to join our Research & Development
-
development: Visas: Applicants for this role will be eligible for sponsorship to work in the UK Generous Leave: 28 days of annual leave, plus three additional days over Christmas and bank holidays. Pension
-
(e.g. Python, Rust) and modern software development techniques (version control, CI/CD) Track record of scientific output and engagement with the computational genomics community Desirable Knowledge
-
an early career development fellow. Before submitting your application please ensure you read the Job Information Pack for full details of this role on our website. This job description set outs
-
The Rosalind Franklin Institute (The Franklin) is the national institute for technology development for the life sciences in the UK – funded by the government through UK Research and Innovation
-
to researchers for the generation of transgenic and genetically modified model organisms. In this rapidly evolving field, we are looking to appoint a dynamic and innovative leader to drive technology development
-
therapeutics. Application of these approaches to Crick translational projects, advising on screening strategy for new targets and supporting the development of assays for compound screening. Contribution
-
a deeper understanding of life, leading to potential acceleration of the development of safe, targeted, cell-based therapies, and opening entire new fields of research in human health. The project